FDA recall D-820-2013

Astellas Pharma US Inc · Class II · drug

Product

AmBisome (amphotericin B) liposome for injection, 50mg vial, single use vial, For Intravenous Infusion Only, Rx Only, Marketed by: Astellas Pharma US, Inc., Northbrook, IL 60062, Manufactured by: Gilead Sciences, Inc, San Dimas, CA 91773, NDC: 0469-3051-30.

Reason for recall

Lack of Assurance of Sterility; Astellas Pharma US, Inc. is performing a voluntary recall on certain lots of AmBisome because the manufacturer has notified Astellas that during a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in the media fills.

Distribution

Nationwide and Canada

Key facts

Status
Terminated
Initiation date
2013-06-19
Report date
2013-07-31
Termination date
2014-02-04
Voluntary/Mandated
Voluntary: Firm initiated
Location
Northbrook, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-820-2013